Roberta Pireddu

876 citations

16 papers · 744 · h-index 10

Impact in

Hematology top 10%
- Acute Myeloid Leukemia Research
Oncology top 10%
- Cytokine Signaling Pathways and Interactions
- Cancer-related Molecular Pathways

Papers in

Molecular Biology 12
- Melanoma and MAPK Pathways 5
- Protein Kinase Regulation and GTPase Signaling 5
- PI3K/AKT/mTOR signaling in cancer 4
- Glycosylation and Glycoproteins Research 2
- Protein Degradation and Inhibitors 2
- Protein Tyrosine Phosphatases 2
Oncology 3

Co-authors: Saı̈d M. Sebti (10 shared papers)Nicholas J. Lawrence (10 shared papers)Harshani R. Lawrence (5 shared papers)E. Schönbrunn (6 shared papers)Mathew P. Martin (6 shared papers)Wayne C. Guida (6 shared papers)Hua Yang (2 shared papers)Yunting Luo (3 shared papers)
Journals: Journal of Medicinal Chemistry (3 papers)Cancer Research (3 papers)MedChemComm (2 papers)ACS Chemical Biology (1 paper)Molecular Cancer Therapeutics (1 paper)
Partner nations: United States Belgium Netherlands

In The Last Decade

Roberta Pireddu

14 papers receiving 728 citations

Peers

Countries citing papers authored by Roberta Pireddu

Since Specialization

Citations

This map shows the geographic impact of Roberta Pireddu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Pireddu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Pireddu more than expected).

Fields of papers citing papers by Roberta Pireddu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Pireddu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Pireddu. The network helps show where Roberta Pireddu may publish in the future.

Co-authors

The 25 scholars most cited alongside Roberta Pireddu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roberta Pireddu Line = papers co-authored together Roberta Pireddu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide Proceedings of the National Academy of Sciences ·Wei Sheng, Xianghong Chen, Kathy Rocha, Pearlie K. Epling‐Burnette, Julie Y. Djeu, Qing Liu, John C. Byrd, Lubomir Sokol, Nick Lawrence, Roberta Pireddu, Gordon W. Dewald, Ann H. Williams, Jaroslaw P. Maciejewski, Alan F. List	2009	148
2	RKI-1447 Is a Potent Inhibitor of the Rho-Associated ROCK Kinases with Anti-Invasive and Antitumor Activities in Breast Cancer Cancer Research ·Ronil A. Patel, Kara D. Forinash, Roberta Pireddu, Ying Sun, Nan Sun, Mathew P. Martin, E. Schönbrunn, Nicholas J. Lawrence, Saı̈d M. Sebti	2012	128
3	A Novel Inhibitor of STAT3 Homodimerization Selectively Suppresses STAT3 Activity and Malignant Transformation Cancer Research ·Xiaolei Zhang, Ying Sun, Roberta Pireddu, Hua Yang, Murali K. Urlam, Harshani R. Lawrence, Wayne C. Guida, Nicholas J. Lawrence, Saı̈d M. Sebti	2013	126
4	Inhibitors of Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (Shp2) Based on Oxindole Scaffolds Journal of Medicinal Chemistry ·Harshani R. Lawrence, Roberta Pireddu, Liwei Chen, Yunting Luo, Shen‐Shu Sung, Ann Marie Szymanski, M.L. Richard Yip, Wayne C. Guida, Saı̈d M. Sebti, Jie Wu, Nicholas J. Lawrence	2008	85
5	Development of o-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors Journal of Medicinal Chemistry ·Harshani R. Lawrence, Mathew P. Martin, Yunting Luo, Roberta Pireddu, Hua Yang, Harsukh Gevariya, Sevil Özcan, J. Zhu, Robert D. Kendig, Mercedes Rodríguez, Roy Elias, Jin Q. Cheng, Saı̈d M. Sebti, E. Schönbrunn, Nicholas J. Lawrence	2012	60
6	A Novel Mechanism by Which Small Molecule Inhibitors Induce the DFG Flip in Aurora A ACS Chemical Biology ·Mathew P. Martin, J. Zhu, Harshani R. Lawrence, Roberta Pireddu, Yunting Luo, Riazul Alam, Sevil Özcan, Saı̈d M. Sebti, Nicholas J. Lawrence, E. Schönbrunn	2012	54
7	Fragment-Based and Structure-Guided Discovery and Optimization of Rho Kinase Inhibitors Journal of Medicinal Chemistry ·Rongshi Li, Mathew P. Martin, Yan Liu, Binglin Wang, Ronil A. Patel, Jin-Yi Zhu, Nan Sun, Roberta Pireddu, Nicholas J. Lawrence, Jiannong Li, Eric B. Haura, Shen‐Shu Sung, Wayne C. Guida, E. Schönbrunn, Saı̈d M. Sebti	2012	47
8	Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinases (ROCK1 and 2) MedChemComm ·Roberta Pireddu, Kara D. Forinash, Nan N. Sun, Mathew P. Martin, Shen‐Shu Sung, Brian Alexander, J. Zhu, Wayne C. Guida, E. Schönbrunn, Saı̈d M. Sebti, Nicholas J. Lawrence	2012	44
9	Development of new N-arylbenzamides as STAT3 dimerization inhibitors MedChemComm ·Murali K. Urlam, Roberta Pireddu, Yiyu Ge, Xiaolei Zhang, Ying Sun, Harshani R. Lawrence, Wayne C. Guida, Saı̈d M. Sebti, Nicholas J. Lawrence	2013	19
10	Rb–Raf-1 Interaction Disruptor RRD-251 Induces Apoptosis in Metastatic Melanoma Cells and Synergizes with Dacarbazine Molecular Cancer Therapeutics ·Sandeep Singh, Rebecca K. Davis, Vignesh K. Alamanda, Roberta Pireddu, Daniel Pernazza, Saı̈d M. Sebti, Nicholas J. Lawrence, Srikumar Chellappan	2010	18
11	Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS. Blood ·Sheng Wei, Kathy Rocha, Ann H. Williams, Xianhong Chen, Pearlie K. Burnette, Julie Y. Djeu, Qing Liu, John C. Byrd, Lubomir Sokol, Nick Lawrence, Roberta Pireddu, Gordon W. Dewald, Jaroslaw P. Maciejewski, Alan F. List	2007	5
12	Reductive lithiation of alkoxy-substituted benzyl methyl ethers and connection with cross-coupling reactions Tetrahedron ·Ugo Azzena, Giovanna Dettori, Roberta Pireddu, Luisa Pisano	2004	5
13	Abstract 3904: Pyridylthiazole-based ureas as inhibitors of Rho-associated protein kinases Cancer Research ·Roberta Pireddu, Kara D. Forinash, Nan N. Sun, Mathew P. Martin, Shen‐Shu Sung, Brian Alexander, J. Zhu, Wayne C. Guida, E. Schönbrunn, Saı̈d M. Sebti, Nicholas J. Lawrence	2012	4
14	inDICEs: a MOOC on Developing Digital Transition Strategies for Cultural Heritage Institutions Lirias (KU Leuven) ·Roberta Pireddu, Frederik Truyen, Sofie Taes, Rasa Bočytė	2022	1
15	Empowering citizen science practices and sustainability in the cultural heritage sector: The CitizenHeritage project Roberta Pireddu	2023	0
16	UPGRADING MOOC STUDENTS' ENGAGEMENT AND PARTICIPATION IN HUMANITIES-ORIENTED ONLINE COURSES: THE EXAMPLE OF THE MOOC BASED ON THE PROJECT “DETECT” Lirias (KU Leuven) ·(unknown), Jan Baetens, Roberta Pireddu, Frederik Truyen	2021	0

About Roberta Pireddu

Roberta Pireddu is a scholar working on Molecular Biology, Oncology, Cell Biology, Organic Chemistry and Hematology, having authored 16 papers that have together received 744 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (5 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Microtubule and mitosis dynamics (3 papers), Glycosylation and Glycoproteins Research (2 papers), Protein Degradation and Inhibitors (2 papers), Protein Tyrosine Phosphatases (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Hematology (130 citations), Oncology (239 citations), Toxicology (31 citations), Molecular Biology (467 citations) and Cell Biology (94 citations). Roberta Pireddu has collaborated with scholars based in United States, Belgium and Netherlands. Frequent co-authors include Saı̈d M. Sebti, Nicholas J. Lawrence, Harshani R. Lawrence, E. Schönbrunn, Mathew P. Martin, Wayne C. Guida, Hua Yang, Yunting Luo, Nan Sun and Ying Sun. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Research, MedChemComm, ACS Chemical Biology and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Roberta Pireddu

Impact in

Papers in i

In The Last Decade

Roberta Pireddu

Peers

Countries citing papers authored by Roberta Pireddu

Fields of papers citing papers by Roberta Pireddu

All Works

About Roberta Pireddu

Explore authors with similar magnitude of impact

Papers in